Form 4: Pediatrix Medical Group Executive Reports Transfer of Shares to Family Trust

Mary Ann E. Moore, EVP, General Counsel, Chief Administrative Officer & Secretary of Pediatrix Medical Group, Inc., reported the transfer of 10,371 shares of common stock to a family trust.

Summary

• Mary Ann E. Moore, an Executive Vice President, General Counsel, Chief Administrative Officer, and Secretary of Pediatrix Medical Group, Inc. (MD), filed a Form 4.
• The filing reports a transaction on June 10, 2025, where 10,371 shares of common stock were transferred.
• The transfer was a gift (transaction code 'G') to a trust for which Ms. Moore and her spouse are trustees, and members of her immediate family are beneficiaries.
• The transaction price was $0, indicating a non-market transfer.
• Following this transaction, Ms. Moore directly beneficially owns 136,242 shares of common stock.
• Additionally, 52,598 shares are indirectly beneficially owned through the trust, with Ms. Moore disclaiming beneficial interest except to the extent of her pecuniary interest.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction (transfer of shares to a family trust) and does not contain information that would significantly alter the company's financial outlook or operational status. It is a neutral filing.

Future Outlook

NA

Industry Context

This document is a routine insider transaction filing (Form 4) and does not provide information related to broader industry trends or competitive landscape. It reflects a personal financial planning decision by a company executive.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a non-market transfer of shares by an executive for personal estate planning, not a sale or purchase that affects market liquidity or valuation.

Key Dates

Keywords

Pediatrix Medical Group, MD, Form 4, Insider Transaction, Share Transfer, Trust, Mary Ann E. Moore, Common Stock